Pharmacy-Based Nonprescription Viagra Sales Expand In U.K.
This article was originally published in The Tan Sheet
Executive Summary
U.K. pharmacy chain Alliance Boots expanded its program to sell Pfizer's Viagra erectile dysfunction drug without a prescription through pharmacists
You may also be interested in...
Pfizer in talks to launch consumer ED product
Undeterred by challenges to switching Viagra (sildenafil), Pfizer is reportedly developing a new Viagra-like erectile dysfunction product in the U.K. that it hopes to sell directly to consumers, according to 1Campaign, an advertising industry publication. A Pfizer spokeswoman would not confirm the potential launch, but noted in an e-mail that the firm "routinely evaluates" drug delivery and formulations. The New York-based firm withdrew its centralized switch application in the EU for Viagra November 2008 for further evaluation after regulators expressed health safety concerns (2"The Tan Sheet" Nov. 24, 2009). Health concerns include negative interactions with nitrates for blood pressure. According to Campaign, Pfizer wants to launch the product in 2011. It reports the product includes the same ingredient as Viagra, but is modified slightly. U.K. pharmacy chain Alliance Boots already sells Rx Viagra without a prescription through pharmacists at 29 stores under the country's Quality Care Commission regulations. A pilot Boots launched in 2007 showed pharmacists effectively could determine whether customers should use Viagra and that the program would prevent abuse by consumers trying to buy the drug for recreational purposes, the chain said in June 2009. Customers must register for the service with Boots and agree to have their doctors notified that they are buying Viagra (3"The Tan Sheet" June 29, 2009)
Plan B Lightning May Strike Again: Complying Will Not End Political Storm
Perpetual political lightning rod - and emergency contraceptive - Plan B has another chance to draw strikes to FDA as the agency has chosen to comply with a court ruling ordering it to reconsider whether the drug should be available in a truly over-the counter setting
Behind The Counter Debate Raises Questions Of Pharmacist Role In Diagnosis
A behind-the-counter class of drugs would inevitably put pharmacists in the position of diagnosing patients' conditions, opponents say